Navigation Links
Medco to Present at the 2010 Citi Investment Research Global Health Care Conference
Date:5/20/2010

FRANKLIN LAKES, N.J., May 20 /PRNewswire-FirstCall/ -- David B. Snow Jr., chairman and chief executive officer, Medco Health Solutions, Inc. (NYSE: MHS), is scheduled to address the 2010 Citi Investment Research Global Health Care Conference in New York on Wednesday, May 26, 2010.

The presentation at the Hilton, New York, will begin at 10 a.m. EDTRichard J. Rubino, Medco's chief financial officer, is also scheduled to attend.

The presentation may be heard live via a simulcast link and the accompanying slides will be available at www.medco.com/investor.  Real Player or Windows Media Player is required to listen to the webcast.  Free downloads of both players are available at the webcast site.  The webcast will be available for replay for one month following the presentation.

About Medco

Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for approximately 65 million members.

With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2009 revenues of nearly $60 billion, Medco ranks 35th on the Fortune 500 list and is named among the world's most innovative, most admired and most trustworthy companies.

For more information, go to http://www.medcohealth.com.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed, and actual results may differ materially from those projected. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. Forward-looking statements in this press release should be evaluated together with the risks and uncertainties that affect our business, particularly those mentioned in the Risk Factors section of the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission.    


'/>"/>
SOURCE Medco Health Solutions, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medco Donates $125,000 to Red Cross for Flood Relief in Tennessee and Other Affected Areas
2. Medco Study: Despite FDA Warnings, Nearly One-Third of Asthma Patients Still Treated with Long-Acting Beta Agonists Without Controller Medications, Increasing Their Risk for Complications and Hospitalizations
3. Medco Announces Webcast for Annual Meeting of Shareholders
4. Medco to Present at Upcoming Investor Conferences
5. Medco to Present at the Deutsche Bank 35th Annual Health Care Conference
6. Medco, Mayo Clinic Study Reveals Using a Simple Genetic Test Reduces Hospitalization Rates by Nearly a Third for Patients on Widely Prescribed Blood Thinner
7. NxStage(R) and Nordic Medcom Sign Distribution Agreement for the System One(TM)
8. Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
9. Medco to Present at Upcoming Investor Conferences
10. Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake
11. Medco, State of Illinois and Community Retail Pharmacies Launch Wired Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2017)... AVIV, Israel, May 29, 2017  Cellect Biotechnology Ltd. ... innovative technology which enables the functional selection of stem ... results for the first quarter ended March 31 st ... with our accomplishments in the first quarter of 2017," ... first quarter, we announced the treatment of the first ...
(Date:5/26/2017)... Calif. , May 25, 2017  In response ... States , Direct Relief is working with Pfizer ... Naloxone available at no cost to community health centers, ... nonprofit providers nationwide. "Pfizer has a ... to medicines and ensuring patient safety through educational activities," ...
(Date:5/23/2017)... 23, 2017  Leaf Healthcare, recognized for developing ... for pressure ulcer prevention, will unveil its comprehensive ... Critical Care Nurses, National Teaching Institute and Critical ... The Leaf Patient Monitoring System is the first ... environment.  The system seamlessly tracks patient movement throughout ...
Breaking Medicine Technology:
(Date:6/20/2017)... ... June 20, 2017 , ... After months of negotiations, FaceCradle USA is proud to announce ... Wednesday, June 21. , “Introducing our product on QVC is something we all worked hard ... travel pillow to more than 90 million homes in the United States,” said FaceCradle USA ...
(Date:6/20/2017)... ... June 20, 2017 , ... EdChoice ... introduction of school choice can promote economic development in economically distressed urban areas. ... according to the report, contributed to the economic development of the city of ...
(Date:6/20/2017)... ... June 20, 2017 , ... Dr. Manju R. ... for leading-edge care, whether or not they have a referral. Dr. Kejriwal offers ... iPlus™ laser, she targets bacteria and damaged tissue without affecting the surrounding tissue. ...
(Date:6/20/2017)... , ... June 20, 2017 , ... ... sites. To understand their regulatory principles, the research team developed expressRNA, a web ... RNA motif analyses. This reveals at nucleotide resolution the ‘RNA maps’, which demonstrate ...
(Date:6/20/2017)... ... , ... John D'Eri, CEO of Rising Tide Car Wash , will ... during the Autism Society of America 's 49th annual conference to be held ... (DJFF) was founded in 2002 as the nation's first autism organization focused exclusively ...
Breaking Medicine News(10 mins):